Texas Oncology, P.A. - Austin — Austin, Texas

Texas Oncology, P.A. - Austin is a clinical research site located in Austin, Texas, United States 78731.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology, P.A. - Austin has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, UC (Urothelial Cancer).

Sponsors: EMD Serono Research & Development Institute, Inc., Incyte Corporation, CanariaBio Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology, P.A. - Austin?

Texas Oncology, P.A. - Austin has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology, P.A. - Austin conducted?

Texas Oncology, P.A. - Austin has 6 clinical trials on record, with 3 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, UC (Urothelial Cancer).

Is Texas Oncology, P.A. - Austin accredited by Crixeo Health?

Yes — Texas Oncology, P.A. - Austin holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology, P.A. - Austin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.